United States

People: Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

12:23pm EDT
Change (% chg)

$0.64 (+1.94%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lanchbury, Jerry 

Dr. Jerry S. Lanchbury Ph.D. is Chief Scientific Officer of Myriad Genetics, Inc. He joined the Company in September 2002 as Senior Vice President of Research. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named to his current position in February 2010. Dr. Lanchbury came to us from GKT School of Medicine, King’s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1st Class Honours, B.Sc. “Biology of Man & his Environment” degree from the University of Aston.

Basic Compensation

Total Annual Compensation, USD 695,642
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,997,860
Fiscal Year Total, USD 2,693,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 135,999 2,950,690.00